Diagnos Inc (DGNOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50 | 360 | 101 | 162 | 77 |
| Marketable Securities | 1,964 | 1,466 | 365 | N/A | 147 |
| Receivables | 87 | 73 | 141 | 124 | 146 |
| TOTAL | $2,161 | $1,939 | $642 | $302 | $405 |
| Non-Current Assets | |||||
| PPE Net | 122 | 147 | 165 | 190 | 211 |
| TOTAL | $122 | $147 | $165 | $190 | $211 |
| Total Assets | $2,283 | $2,086 | $806 | $492 | $616 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,910 | 1,315 | 1,311 | 724 | 136 |
| Accounts payable and accrued liabilities | 277 | 367 | 231 | 387 | 368 |
| TOTAL | $2,270 | $1,772 | $1,634 | $1,202 | $580 |
| Non-Current Liabilities | |||||
| Long Term Debt | 148 | 158 | 160 | 166 | 138 |
| Deferred Revenues | N/A | 6 | 7 | 6 | 15 |
| Other Non-Current Liabilities | 160 | 758 | 707 | 1,277 | 1,862 |
| TOTAL | $354 | $984 | $955 | $1,552 | $2,152 |
| Total Liabilities | $2,624 | $2,756 | $2,588 | $2,754 | $2,732 |
| Shareholders' Equity | |||||
| Common Shares | 30,741 | 30,426 | 28,495 | 27,947 | 27,173 |
| Retained earnings | -38,278 | -38,397 | -37,531 | -37,545 | -36,601 |
| Other shareholders' equity | 7,197 | 7,300 | 7,255 | 7,335 | 7,312 |
| TOTAL | $-341 | $-670 | $-1,782 | $-2,262 | $-2,116 |
| Total Liabilities And Equity | $2,283 | $2,086 | $806 | $492 | $616 |